9-5339695-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006911.4(RLN1):āc.52C>Gā(p.Gln18Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,613,286 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006911.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RLN1 | NM_006911.4 | c.52C>G | p.Gln18Glu | missense_variant | 1/2 | ENST00000223862.2 | NP_008842.1 | |
RLN1 | XM_047423703.1 | c.52C>G | p.Gln18Glu | missense_variant | 1/3 | XP_047279659.1 | ||
RLN1 | XM_047423706.1 | c.-48+1126C>G | intron_variant | XP_047279662.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RLN1 | ENST00000223862.2 | c.52C>G | p.Gln18Glu | missense_variant | 1/2 | 1 | NM_006911.4 | ENSP00000223862.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151510Hom.: 0 Cov.: 27
GnomAD3 exomes AF: 0.0000955 AC: 24AN: 251362Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135868
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461658Hom.: 1 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 727142
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151628Hom.: 0 Cov.: 27 AF XY: 0.00 AC XY: 0AN XY: 74158
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2024 | The c.52C>G (p.Q18E) alteration is located in exon 1 (coding exon 1) of the RLN1 gene. This alteration results from a C to G substitution at nucleotide position 52, causing the glutamine (Q) at amino acid position 18 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at